scholarly journals Short-Term Efficacy of Epidural Injection of Triamcinolone Through Translaminar Approach for the Treatment of Lumbar Canal Stenosis

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Saeed Sabbaghan ◽  
Elham Mirzamohammadi ◽  
Maryam Ameri Mahabadi ◽  
Farshad Nikouei ◽  
Farhad Rahbarian ◽  
...  
Keyword(s):  
Epidural Injection ◽  
Short Term ◽  
Lumbar Canal Stenosis ◽  
Term Efficacy ◽  
Canal Stenosis ◽  
Translaminar Approach

Comparison of Short-Term Clinical Results and Radiologic Changes Between Two Different Minimally Invasive Decompressive Surgical Methods for Lumbar Canal Stenosis

Spine ◽  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Sunao Tanaka ◽  
Kanichiro Wada ◽  
Gentaro Kumagai ◽  
Toru Asari ◽  
Shuichi Aburakawa ◽  
...  
Keyword(s):  
Minimally Invasive ◽  
Clinical Results ◽  
Short Term ◽  
Lumbar Canal Stenosis ◽  
Canal Stenosis ◽  
Surgical Methods

scholarly journals Short-term Clinical Outcomes of Muscle-preserving Interlaminar Decompression (MILD) for the Lumbar Canal Stenosis

2010 ◽  
Vol 59 (2) ◽  
pp. 271-274
Author(s):  
Ryusaku Nagayoshi ◽  
Kosei Ijiri ◽  
Hikaru Sakamoto ◽  
Takuya Yamamoto ◽  
Kazunori Yone ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Short Term ◽  
Lumbar Canal Stenosis ◽  
Canal Stenosis

Short‐term efficacy of a gel containing propolis extract, nanovitamin C and nanovitamin E on peri‐implant mucositis: A double‐blind, randomized, clinical trial

2021 ◽  
Author(s):  
José González‐Serrano ◽  
Rosa María López‐Pintor ◽  
Julia Serrano ◽  
Jesús Torres ◽  
Gonzalo Hernández ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Short Term ◽  
Double Blind ◽  
Propolis Extract ◽  
Term Efficacy

scholarly journals Evaluation of the short-term efficacy of local analgesic (lidocaine) and opioid analgesic (sufentanil) on patients with centrally mediated abdominal pain syndrome: a randomized controlled trial

2021 ◽  
Vol 14 ◽  
pp. 175628482110217
Author(s):  
Hang Yang ◽  
Honglin Chen ◽  
Bing Hu
Keyword(s):  
Randomized Controlled Trial ◽  
Abdominal Pain ◽  
Rating Scales ◽  
Rating Scale ◽  
Controlled Trial ◽  
Opioid Analgesic ◽  
Pain Syndrome ◽  
Short Term ◽  
Randomized Controlled ◽  
Term Efficacy

Background: Centrally mediated abdominal pain syndrome (CAPS) is characterized by continuous or frequently recurring abdominal pain and can result in functional loss across several life domains. The efficacy of the present management methods has not been established yet. We performed a prospective randomized controlled trial to explore the short-term efficacy of local analgesic (lidocaine) and opioid analgesic (sufentanil) in patients with CAPS. Methods: We consecutively enrolled 130 patients who met the Rome IV CAPS criteria and divided them into the sufentanil + lidocaine (S + L) group and sufentanil (S) group. Patients completed the pain rating scales, including the numeric rating scale (NRS) and verbal rating scale (VRS), 60 min before colonoscopy. All the patients were initially administered sufentanil. In the S + L group, we sprayed a 5 ml solution of lidocaine on the surface of ascending, transverse, descending, and sigmoid colon during colonoscope withdrawal, while 5 ml saline was sprayed in the S group. Follow up was performed 1 day, 3 days, 1 week, 2 weeks, 1 month, and 3 months after colonoscopy, to complete the pain scaling. Results: A comparison of the NRS and VRS showed that there were no significant differences between the S + L and S groups and within each group ( p > 0.05). Conclusions: Local analgesic lidocaine and opioid analgesic sufentanil showed negative efficacy during short-term observation. The opioid receptor blocker sufentanil did not worsen symptoms in patients with CAPS after colonoscopy under general anesthesia in the short term. [chictr.org.cn, Chinese Clinical Trial Identifier, ChiCTR-IOR-16008187]

Sign in / Sign up

Export Citation Format

Share Document